Sure Shot Genetics LLC

Testing facility specializing in genetic testing for hemp/...


Private Fundraise

This company may be interested in raising funds from accredited investors. You must Request Access to see more information about this company.

Request Access 9

Fast Facts

Sure Shot Genetics is a testing facility for the hemp and cannabis industry.
We provide genetic analysis and genomic profiling for future industry decisions.

New Industry Requires New Standards

Helping Fill The Testing Void

Sure Shot Genetics will provide industry growers the testing they need so they can make better decisions. Understanding the genetic expression and make up of your strain will be key to maximizing the potential of the product as well as planning for future success.  The need for more in-depth testing will become more important as the industry grows and matures. At present very few facilities are available to do this.

We analyze specific DNA expressions to identify desirable traits so growers can:

Traction & Accomplishments

Product Development

Meet the Team

Bradley Hawes - CFO
Is a trained accountant with a track record of scaling small proven companies, improving operational efficiencies, and providing complex loan structures. An analytical problem solver that has taken a company with $10 million in sales to $70 million in two years. Experienced in leading and building teams and procedures to fit operational needs.

Michael Edwards - Head of Development and Data analysis
Former University of Colorado assistant professor and director of the Bioinformatics Core at the Lung Cancer Center  SPORE (Specialized Program of Research Excellence) at the Anschutz Medical Center.  Mike has over 15 years of experience working with array-based genomic studies and analyzing next-generation sequencing data, which includes single cell genomics, whole/exome sequencing and global transcription. Extensively published and provides a workshop program for American Association of Cancer Research (AACR). Mike has a PHD from University of Wisconsin Madison in Genetics, an alum of CSU and University of Texas.

Chris Coldren – Head of Laboratory Facilities
Chris is a PHD bioinformatician and clinical laboratory professional who in the past developed strategies and capabilities for genomic oncology. Mr. Coldren, has provided genomic analysis and design for DuPont MIT, YALE, National Jewish, CU, and  Vanderbilt University. An experienced bioinformatician and clinical laboratory professional. He has overseen the reorganization of multiple genomic core labs under a single management structure.  He has radically improved compliance and cost performance. While a member of the Advanced Genomic Analysis and Research Design (VANGARD) group at Vanderbilt University, he established the “Research Design Studio” at Vanderbilt University.

Lawrence Perle - Head of Management and Marketing
A serial entrepreneur, involved in creating and advising emerging tech companies. Recently raised capital for a cardio diagnostic company.  Knowledgeable in the VC and PE community. History of overseeing company growth from inception to exit. Managed over 300 people at a large reinsurance company.  Managed a multi million marketing budget. Negotiated with the state for 2 mil in Econ development funding. A graduate of University of Denver MBA program.

The Business Plan area is locked. You must Request Access to this company to see more information including the Business Plan.

Request Access


No updates yet.


No backers yet.

Quick Signup TBD

You must have an account to do this!

the platform

Copyright © 2019 All rights reserved.

Fundable is a software as a service crowdfunding platform. Fundable is not a registered broker-dealer and does not offer investment advice or advise on the raising of capital through securities offerings. Fundable does not recommend or otherwise suggest that any investor make an investment in a particular company, or that any company offer securities to a particular investor. Fundable takes no part in the negotiation or execution of transactions for the purchase or sale of securities, and at no time has possession of funds or securities. No securities transactions are executed or negotiated on or through the Fundable platform. Fundable receives no compensation in connection with the purchase or sale of securities.